Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Cell Commun Signal
2015 Mar 01;91:5-13. doi: 10.1007/s12079-015-0271-0.
Show Gene links
Show Anatomy links
The NOTCH signaling pathway in normal and malignant blood cell production.
Suresh S
,
Irvine AE
.
???displayArticle.abstract???
The NOTCH pathway is an evolutionarily conserved signalling network, which is fundamental in regulating developmental processes in invertebrates and vertebrates (Gazave et al. in BMC Evol Biol 9:249, 2009). It regulates self-renewal (Butler et al. in Cell Stem Cell 6:251-264, 2010), differentiation (Auderset et al. in Curr Top Microbiol Immunol 360:115-134, 2012), proliferation (VanDussen et al. in Development 139:488-497, 2012) and apoptosis (Cao et al. in APMIS 120:441-450, 2012) of diverse cell types at various stages of their development. NOTCH signalling governs cell-cell interactions and the outcome of such responses is highly context specific. This makes it impossible to generalize about NOTCH functions as it stimulates survival and differentiation of certain cell types, whereas inhibiting these processes in others (Meier-Stiegen et al. in PLoS One 5:e11481, 2010). NOTCH was first identified in 1914 in Drosophila and was named after the indentations (notches) present in the wings of the mutant flies (Bigas et al. in Int J Dev Biol 54:1175-1188, 2010). Homologs of NOTCH in vertebrates were initially identified in Xenopus (Coffman et al. in Science 249:1438-1441, 1990) and in humans NOTCH was first identified in T-Acute Lymphoblastic Leukaemia (T-ALL) (Ellisen et al. in Cell 66:649-61, 1991). NOTCH signalling is integral in neurogenesis (Mead and Yutzey in Dev Dyn 241:376-389, 2012), myogenesis (Schuster-Gossler et al. in Proc Natl Acad Sci U S A 104:537-542, 2007), haematopoiesis (Bigas et al. in Int J Dev Biol 54:1175-1188, 2010), oogenesis (Xu and Gridley in Genet Res Int 2012:648207, 2012), differentiation of intestinal cells (Okamoto et al. in Am J Physiol Gastrointest Liver Physiol 296:G23-35, 2009) and pancreatic cells (Apelqvist et al. in Nature 400:877-881, 1999). The current review will focus on NOTCH signalling in normal and malignant blood cell production or haematopoiesis.
Fig. 1.
NOTCH receptors. The mammalian NOTCH family has four members NOTCH1-4; all consist of extracellular and intracellular domains. The extracellular domain 29â36 Epidermal growth factor (EGF) like repeats followed by three Lin-NOTCH repeats (LNR). The intracellular domain has the RBP-J-associated molecule (RAM) domain, six ankyrin repeats (ANK), nuclear localization sequences (NLS), a transactivation domain (TAD) required for activating transcription and a proline-, glutamate-, serine- and threonine-rich (PEST) domain which regulates NOTCH degradation. NOTCH1 and NOTCH2 are structurally similar, NOTCH3 and NOTCH4 are smaller proteins as they have fewer EGF repeats and lack TAD
Fig. 2.
NOTCH signaling pathway. In the golgi apparatus the Notch receptor undergoes proteolytic processing, which is S1 cleavage mediated by Furin proteases. The receptor is transported to the cell surface membrane. The extracellular domain of the Notch receptor (Notch-ECD) in the signalling cell binds with the Notch ligands (Delta, Jagged, Serrate) expressed by the adjacent cell. This induces the second proteolytic step, S2 cleavage by ADAM metalloproteases, and leads to the endocytosis of the Notch-ECD into the ligand-expressing cell. This is followed by the release of the Notch intracellular domain (Notch-ICD) with a tethered membrane. This is now a substrate for the gamma secretase enzyme complex, which cleaves the Notch-ICD from the membrane by S3 and S4 cleavages. The resulting active Notch-ICD translocates to the nucleus and interacts with the CSL protein. In the absence of Notch-ICD, the CSL is bound to co-repressor. Binding of Notch-ICD with CSL results in the formation of an active complex with MAML and other co-activators and leads to the transcription of Notch targets HES and HEY
Fig. 3.
Haematopoiesis. Blood cell production is maintained by a small population of stem cells found in the bone marrow; these cells have the ability to self-renew or differentiate. Cells then differentiate to multi-potential and lineage committed progenitors; these cells canât be distinguished morphologically, only by the use of clonogenic assays. The final stage of differentiation is when the cells develop their characteristic morphology and are released into the circulation
Adamia,
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML.
2014, Pubmed
Adamia,
NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML.
2014,
Pubmed
Adler,
Notch signaling augments T cell responsiveness by enhancing CD25 expression.
2003,
Pubmed
Allman,
Notch signaling in hematopoiesis and early lymphocyte development.
2002,
Pubmed
Andersen,
Non-canonical Notch signaling: emerging role and mechanism.
2012,
Pubmed
Andersson,
Notch signaling: simplicity in design, versatility in function.
2011,
Pubmed
Artavanis-Tsakonas,
Notch signaling: cell fate control and signal integration in development.
1999,
Pubmed
Bellavia,
Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
2002,
Pubmed
Benveniste,
Notch signals are required for in vitro but not in vivo maintenance of human hematopoietic stem cells and delay the appearance of multipotent progenitors.
2014,
Pubmed
Bigas,
The Notch pathway in the developing hematopoietic system.
2010,
Pubmed
Brou,
A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE.
2000,
Pubmed
Butler,
Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells.
2010,
Pubmed
Chiaramonte,
A wide role for NOTCH1 signaling in acute leukemia.
2005,
Pubmed
Cohen,
Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
2010,
Pubmed
Delaney,
Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.
2010,
Pubmed
Delaney,
Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells.
2005,
Pubmed
de Pooter,
Notch signaling requires GATA-2 to inhibit myelopoiesis from embryonic stem cells and primary hemopoietic progenitors.
2006,
Pubmed
Deregowski,
Role of the RAM domain and ankyrin repeats on notch signaling and activity in cells of osteoblastic lineage.
2006,
Pubmed
De Strooper,
A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.
1999,
Pubmed
D'Souza,
The many facets of Notch ligands.
2008,
Pubmed
Duncan,
Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance.
2005,
Pubmed
Fabbri,
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.
2011,
Pubmed
Fernández-Sánchez,
In vitro effects of stromal cells expressing different levels of Jagged-1 and Delta-1 on the growth of primitive and intermediate CD34(+) cell subsets from human cord blood.
2011,
Pubmed
Gordon,
The molecular logic of Notch signaling--a structural and biochemical perspective.
2008,
Pubmed
Guo,
Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
2009,
Pubmed
Hayward,
Notch modulates Wnt signalling by associating with Armadillo/beta-catenin and regulating its transcriptional activity.
2005,
Pubmed
Hozumi,
Notch signaling is necessary for GATA3 function in the initiation of T cell development.
2008,
Pubmed
Iso,
HES and HERP families: multiple effectors of the Notch signaling pathway.
2003,
Pubmed
Kannan,
Notch activation inhibits AML growth and survival: a potential therapeutic approach.
2013,
Pubmed
Klinakis,
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia.
2011,
Pubmed
Kojika,
Notch receptors and hematopoiesis.
2001,
Pubmed
Kopan,
The canonical Notch signaling pathway: unfolding the activation mechanism.
2009,
Pubmed
Kumano,
Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells.
2003,
Pubmed
Kunisato,
HES-1 preserves purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo.
2003,
Pubmed
Lai,
Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins.
2002,
Pubmed
Lake,
In vivo analysis of the Notch receptor S1 cleavage.
2009,
Pubmed
Lam,
Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by notch-1.
2000,
Pubmed
Lee,
Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma.
2009,
Pubmed
Lobry,
Notch pathway activation targets AML-initiating cell homeostasis and differentiation.
2013,
Pubmed
Logeat,
The Notch1 receptor is cleaved constitutively by a furin-like convertase.
1998,
Pubmed
Lubman,
Quantitative dissection of the Notch:CSL interaction: insights into the Notch-mediated transcriptional switch.
2007,
Pubmed
Maillard,
Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells.
2008,
Pubmed
Marambaud,
A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions.
2002,
Pubmed
Masiero,
Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
2011,
Pubmed
Mizuno,
Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.
2008,
Pubmed
Moellering,
Direct inhibition of the NOTCH transcription factor complex.
2009,
Pubmed
Mohtashami,
Direct comparison of Dll1- and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes.
2010,
Pubmed
Moloney,
Fringe is a glycosyltransferase that modifies Notch.
2000,
Pubmed
Monastirioti,
Drosophila Hey is a target of Notch in asymmetric divisions during embryonic and larval neurogenesis.
2010,
Pubmed
Murakami,
Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44.
2003,
Pubmed
Nakahara,
Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia.
2010,
Pubmed
Ohishi,
Notch signalling in hematopoiesis.
2003,
Pubmed
Okajima,
Modulation of notch-ligand binding by protein O-fucosyltransferase 1 and fringe.
2003,
Pubmed
O'Neil,
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.
2007,
Pubmed
Palomero,
Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias.
2006,
Pubmed
Rebay,
Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor.
1991,
Pubmed
,
Xenbase
Ren,
Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.
2011,
Pubmed
Robert-Moreno,
RBPjkappa-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells.
2005,
Pubmed
Rosati,
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells.
2009,
Pubmed
Rossi,
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.
2012,
Pubmed
Schwanbeck,
The Notch signaling pathway in hematopoiesis and hematologic malignancies.
2011,
Pubmed
Shimizu,
Mouse jagged1 physically interacts with notch2 and other notch receptors. Assessment by quantitative methods.
1999,
Pubmed
Staal,
Signaling pathways involved in the development of T-cell acute lymphoblastic leukemia.
2008,
Pubmed
Stier,
Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome.
2002,
Pubmed
Suresh,
The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia.
2013,
Pubmed
Takebe,
Targeting notch signaling pathway in cancer: clinical development advances and challenges.
2014,
Pubmed
Tani,
The N- and C-terminal regions of RBP-J interact with the ankyrin repeats of Notch1 RAMIC to activate transcription.
2001,
Pubmed
Tien,
A Notch updated.
2009,
Pubmed
Tohda,
Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells.
2001,
Pubmed
Tohda,
Diverse effects of the Notch ligands Jagged1 and Delta1 on the growth and differentiation of primary acute myeloblastic leukemia cells.
2005,
Pubmed
Tran,
Blockade of individual Notch ligands and receptors controls graft-versus-host disease.
2013,
Pubmed
Trøen,
NOTCH2 mutations in marginal zone lymphoma.
2008,
Pubmed
Varnum-Finney,
Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells.
2011,
Pubmed
Varnum-Finney,
Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling.
2000,
Pubmed
Varnum-Finney,
Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability.
2003,
Pubmed
Vercauteren,
Constitutively active Notch4 promotes early human hematopoietic progenitor cell maintenance while inhibiting differentiation and causes lymphoid abnormalities in vivo.
2004,
Pubmed
Vidal,
Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.
2005,
Pubmed
Walker,
The notch receptor and its ligands are selectively expressed during hematopoietic development in the mouse.
2001,
Pubmed
Weerkamp,
Identification of Notch target genes in uncommitted T-cell progenitors: No direct induction of a T-cell specific gene program.
2006,
Pubmed
Weng,
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma.
2006,
Pubmed
Weng,
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
2004,
Pubmed
Wu,
Therapeutic antibody targeting of individual Notch receptors.
2010,
Pubmed
Zhang,
Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
2013,
Pubmed
